Stock UDJ APPLIED DNA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Applied DNA Sciences, Inc. BOERSE MUENCHEN

Equities

UDJ

US03815U4094

Market Closed - BOERSE MUENCHEN
Other stock markets
 20:44:16 28/06/2024 BST 		5-day change 1st Jan Change
0.414 EUR 0.00% Intraday chart for Applied DNA Sciences, Inc. -0.48% -96.49%
06-20 Applied DNA Sciences, Inc. and Alphazyme LLC Conclude Linea (TM) RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement in Linea (TM) IVT Platform Economics CI
06-18 Applied DNA Partners With GenXys For Pharmacogenetic Testing MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Applied DNA and Alphazyme Conclude Linea RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea IVT Platform Economics
AQ
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic Testing
AQ
Applied DNA Sciences : Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
PU
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea IVT Platform
AQ
Applied DNA Announces Pricing of $12 Million Public Offering
AQ
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
AQ
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot
AQ
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
AQ
Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress
AQ
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot
AQ
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
AQ
Applied DNA Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow
AQ
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot
AQ
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
AQ
Applied DNA Extends Application of Linea IVT Platform to saRNA
AQ
Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production
AQ
Applied DNA Sciences: Fiscal Q3 Earnings Snapshot
AQ
Conference Call/Webcast Scheduled for Today at 4:30 PM ET - Form 8-K
PU
Applied DNA Biotherapeutics Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences
AQ
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APDN Stock
  4. UDJ Stock
  5. News Applied DNA Sciences, Inc.
  6. Press Releases